University of Navarra, Dept. of Food Science and Physiology, Center for Nutrition Research
Pamplona, Navarre, 31008, Spain
NCT Number: NCT05619276
Obesity has reached epidemic proportions globally, alongside its associated comorbidities including cardiovascular diseases, diabetes and cancer. Effective weight management strategies are thus paramount to improve the population´s health. One of the key causes of obesity lies in excessive energy consumption derived from eating too large portions of food. In this context, practical tools to control portion size represent a promising, cost-effective strategy.
This study will investigate whether using an optimized portion-control toolkit to consume a meal under controlled laboratory conditions has a positive effect on the nutritional quality of the meal as well as any benefits in physiological, cognitive, affective and behavioural outcomes.
The study will involve 40 volunteers with overweight or obesity who will attend two lunch sessions at the Center for Nutrition Research of the University of Navarra (Spain) on two different days. At each session, participants will be invited to self-serve and eat a lunch from a cold buffet. On day one, participants will self-serve and season their food using control tools (conventional kitchen serving spoons and oil dispenser). On day two, participants will self-serve the same foods as on day one but using experimental tools (calibrated portion-control serving spoons and calibrated oil dispenser). A set of cognitive tests will be completed before, during and after the meal.
Conventional and experimental tools will be compared in terms of the following variables: meal portion size and energy density, cognitive effort while serving food, cephalic and intestinal satiety responses, appetite sensations, energy adjustment post-meal, awareness of the quantities of the previously consumed foods and recalibration of portion size norms. Additionally, the study will explore acceptance for and intention to use the optimized portion control toolkit, as well as intention to change eating habits.
It is expected that the findings from this study will shed light into the cognitive and physiological processes associated with portion control. It may also help to explain individual variations in the responses to obesogenic environments, which will hopefully lead to improved personalized interventions.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Pamplona, Navarre, 31008, Spain
Study justification:
The prevalence of obesity and associated health-risks (e.g. cardiovascular disease, diabetes and cancer) continues to increase across the globe, raising the need for effective weight management strategies to improve the population´s health. High rates of obesity respond at least in part, to the current obesogenic environment that prompts people to overeat both in terms of energy and amount. In this context, access to practical tools that can help individuals control their portion sizes represent a promising, cost-effective strategy. However, urging people to "eat less" of all foods might be challenging as individuals are used to consume a certain volume of food to feel satisfied. Instead, a more effective approach may be to help people lower the energy density of their meals through the increase in the amount of fruits and vegetables in their diet at the expense of high energy density foods, such as foods rich in fat and starch. Portion-control plates and serving utensils, designed to measure the appropriate amounts and proportions of main food groups (e.g. starch, protein and vegetables), can actually facilitate this shift. Our recent systematic review (https://pubmed.ncbi.nlm.nih.gov/34207492/) found that portion-control plates in particular were the most promising tools to regulate intake and develop healthier eating habits. However, some of the studies conducted up to date have explored the effect of different portion control tools in combination with other weight management strategies, making it difficult to determine the impact of these instruments on their own. The design of the tools may also negatively affect success if instruments don´t fit the user´s lifestyle and eating routines. Individual characteristics such as sex and BMI have also been found to modulate the success of portion control tools. Therefore, optimizing the current tools is needed to achieve a wider impact.
Specific aims:
The primary goal of the present study is to investigate the acute effects of using a portion control tableware toolkit, optimized based on our previous quantitative and qualitative work with portion control tableware, in people with overweight and obesity. The intervention will be conducted under controlled laboratory conditions in order to obtain proof of concept of the toolkit efficacy before application into field studies. The secondary goal is to gain knowledge on the cognitive and physiological mechanisms involved in portion size regulation mediated by portion control tools.
It is expected that the findings from this study will shed light into the cognitive and physiological processes associated with portion control. It may also help to explain individual variations in the responses to obesogenic environments, which will hopefully lead to improved personalized interventions. The ultimate goal is to develop effective, easy, attractive and affordable strategies that could help individuals prevent overeating.
Study design:
This will be a non-randomized within-subjects laboratory study which will involve two sessions, of approximately 3 - hour duration each, conducted at lunchtime at the Center for Nutrition Research of the University of Navarra (Pamplona) on two different days, with a 7 to 11 day wash-out period. At each session, participants will be invited to self-serve and eat a lunch from a cold buffet in the laboratory. On day one, participants will self-serve and season their food using control tools (conventional kitchen serving spoons and oil dispenser). On day two, participants will be invited to self-serve the same foods as on day one but using experimental tools (calibrated portion control serving spoons and calibrated oil dispenser). On both days, the food will be served on a standard (25 cm in diameter), white dish without markings or illustrations, and participants will eat using standard cutlery. A set of cognitive tests will be completed before, during and after the meal. All participants will receive a give-away tool in compensation for their time.
Study procedures:
Experimental buffet:
The experimental buffet has been designed to include foods from each of the main food groups in line with the USDA MyPlate model. The foods include: vegetables (cherry tomatoes, green leaves and bell pepper), protein (cooked chopped chicken breasts, canned tuna and mozzarella cheese pearls) a starchy food (cooked quinoa and pasta). Chickpeas are also included as starchy food although they contain some protein. Fruit including apples, oranges and canned pineapple, is included as optional dessert. Complimentary bread, condiments (olive oil, salt, and pepper) and non-carbonated water will also be offered.
All foods and water will be served cold (or at room temperature) on separate trays set up in a buffet-style and in sufficient amounts to allow eating until comfortably full and to avoid ceiling effects (e.g. at least double the amount of the average portion). To standardize the two study conditions, participants will be asked to select the same foods on both laboratory visits. Each participant will choose his/her own experimental meal during the screening session, thereby preventing any unnecessary food waste.
Recruitment and Screening:
The sample size for this study was estimated using the open source software GPower. For a 2-sided paired comparison, a sample of 34 completers would allow detection of significant between-conditions differences, with alpha 0.05 and 80% power, in variables related to selected portion size (main outcome measure: consumed carbohydrate portion size), cognitive effort, and cephalic and intestinal satiety responses. Assuming a 15% drop-out (based on an observed 10% rate in our previous study) the recruitment target will be 40 healthy adults with overweight or obesity. Whenever possible, a balanced representation of men and women will be ensured, so that neither sex constitutes more than 60% (or less than 40%) of the sample. Potential participants will be recruited through advertisements in the local press, through social media, university newsletters, at health and community centres, pharmacies, shops, schools, etc., and from the volunteer database from the Center for Nutrition Research of the University of Navarra.
Initial verification of the inclusion/exclusion criteria will be performed via a telephone interview. If the initial criteria are met, candidates will be sent via email a link and ID code to complete the Eating Attitudes Test (EAT-26) and the Perceived Stress Scale (PSS-14) online, via Google Forms. Those who meet the EAT-26 and PSS-14 criteria (see Eligiblity Criteria section) will be invited to the screening session in the laboratory for anthropometric measurements, experimental food tasting, and an eye-tracking familiarization test.
Assessment:
The following questionnaires will be administered to collect data for later sample description and analysis of potential variables that could influence eating habits and hence study results:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Menstrual cycle in women will not be controlled for but day of last menstruation in pre-menopausal women will be recorded. Post-menopausal women will not be excluded; however, this detail will be noted at screening, with an individual's menopausal status (pre, peri or post).
Candidates working shifts may be eligible if they are able to attend a clinical visit at least 12 hours since the last shift, to ensure they have sufficient sleep and their appetite sensations are not altered.
Serving a meal using standard kitchen utensils (100% of subjects experiment with these tools first)
Other names: Standard serving spoon set and standard oil dispenser
Serving a meal using optimised, portion-control utensils (100% of subjects experiment with these tools second)
Other names: Calibrated serving spoon set and calibrated oil dispenser
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of consumed carbohydrate
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of consumed protein
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of consumed vegetables
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of consumed fat
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of consumed fibre
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of served carbohydrate
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of served protein
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of served vegetables
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of served fat
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Grams of served fibre
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood glucose levels at 7 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood glucose levels at 12 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood glucose levels at 32 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood glucose levels at 62 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood glucose levels at 92 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood insulin levels at 7 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood insulin levels at 12 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood insulin levels at 32 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood insulin levels at 62 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood insulin levels at 92 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood pancreatic polypeptide levels at 7 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood pancreatic polypeptide levels at 12 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood pancreatic polypeptide levels at 32 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood pancreatic polypeptide levels at 62 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood pancreatic polypeptide levels at 92 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood total ghrelin levels at 7 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood total ghrelin levels at 12 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood total ghrelin levels at 32 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood total ghrelin levels at 62 min post-meal
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Blood total ghrelin levels at 92 min post-meal
Time frame: Clinical Investigation Day 1
Duration of the serving time for the meal (min) at the first serving
Time frame: Clinical Investigation Day 2
Duration of the serving time for the meal (min) at the first serving
Time frame: Clinical Investigation Day 1
Duration of the visual fixation time while serving the meal (sec) at the first serving
Time frame: Clinical Investigation Day 2
Duration of the visual fixation time while serving the meal (sec) at the first serving
Time frame: Clinical Investigation Day 1
Dilation of the pupil while serving the meal (mm) at the first serving
Time frame: Clinical Investigation Day 2
Dilation of the pupil while serving the meal (mm) at the first serving
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Fasting blood glucose levels
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Fasting blood insulin levels
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Fasting blood pancreatic polypeptide levels
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Fasting blood ghrelin levels
Time frame: Clinical Investigation Day 1
Average 5-Pt Likert scores for portion tool acceptance, ease of use, perceived effectiveness and intention to use (previously piloted questionnaire), after self-serving of the meal and before meal consumption. An average score of 1 or 2 indicates low acceptance, 3 neutral, and 4 or 5 high acceptance.
Time frame: Clinical Investigation Day 2
Average 5-Pt Likert scores for portion tool acceptance, ease of use, perceived effectiveness and intention to use (previously piloted questionnaire), after self-serving of the meal and before meal consumption. An average score of 1 or 2 indicates low acceptance, 3 neutral, and 4 or 5 high acceptance.
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Subjective cognitive effort (self-constructed questionnaire), after self-serving of the meal and before meal consumption. A higher score indicates a greater perceived effort in conducting the task.
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Intention to change eating habits and to maintain the newly acquired habits (self-constructed questionnaire), after self-serving of the meal and before meal consumption. A higher score indicates a stronger intention to change and/or perceived capacity to achieve the desired change.
Time frame: Clinical Investigation Day 1
Area Under the Curve for hunger levels calculated from the 100 mm visual analogue scale scores for hunger before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 2
AUC for hunger levels calculated from the 100 mm visual analogue scale scores for hunger before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 1
Area Under the Curve for fullness levels calculated from the 100 mm visual analogue scale scores for fullness before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 2
Area Under the Curve for fullness levels calculated from the 100 mm visual analogue scale scores for fullness before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 1
Area Under the Curve for thirst levels calculated from the 100 mm visual analogue scale scores for thirst before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 2
Area Under the Curve for thirst levels calculated from the 100 mm visual analogue scale scores for thirst before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 1
Area Under the Curve for prospective intake levels calculated from the 100 mm visual analogue scale scores for thirst before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 2
Area Under the Curve for prospective intake levels calculated from the 100 mm visual analogue scale scores for thirst before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 1
Area Under the Curve for nausea levels calculated from the 100 mm visual analogue scale scores for thirst before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 2
Area Under the Curve for nausea levels calculated from the 100 mm visual analogue scale scores for thirst before the meal and at 30, 60, 90 and 120 min after meal initiation (validated questionnaire)
Time frame: Clinical Investigation Day 1
100 mm visual analogue scale scores for expected satiety of the meal (published scale), after self-serving of the meal, before meal consumption. A higher score indicates that the meal is perceived as more satiating.
Time frame: Clinical Investigation Day 2
100 mm visual analogue scale scores for expected satiety of the meal (published scale), after self-serving of the meal, before meal consumption. A higher score indicates that the meal is perceived as more satiating.
Time frame: Clinical Investigation Day 1
100 mm VAS scores for how much the served portion of the whole meal, starch, vegetables and protein differs from an habitual portion (published questionnaire), at 30 min after meal initiation. A score above 50 mm indicates that the participant's habitual portion size is larger than the portion size being evaluated.
Time frame: Clinical Investigation Day 2
100 mm visual analogue scale scores for how much the served portion of the whole meal, starch, vegetables and protein differs from an habitual portion (published questionnaire), at 30 min after meal initiation. A score above 50 mm indicates that the participant's habitual portion size is larger than the portion size being evaluated.
Time frame: Clinical Investigation Day 1
100 mm visual analogue scale scores for liking of the meal (pre-piloted scale), at 30 min after meal initiation. A higher score indicates higher liking for the meal.
Time frame: Clinical Investigation Day 2
100 mm visual analogue scale scores for liking of the meal (pre-piloted scale), at 30 min after meal initiation. A higher score indicates higher liking for the meal.
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Energy (kcal) intake during the the 8 h following the laboratory visit, calculated from food data registered in an estimated food diary (published method)
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Percent energy compensation during the the 8 h following the laboratory visit, calculated from food data registered in an estimated food diary (published method)
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Percent error between actual (g) and recalled (g) portion sizes for the foods consumed at the laboratory lunch, using a computerised task at 120 min after meal initiation (published method)
Time frame: Clinical Investigation Day 1, Clinical Investigation Day 2
Percent error between recreated portion sizes (g) and recommended portion sizes (g) for a sample of representative foods, using an on-line computerised task, before bed time (unpublished method)
Time frame: Screening visit
Descriptive profile composed of self-reported age, gender, educational level, ethnic origin, marital status, household composition, employment, meal composition and patterns, main shopper
Time frame: Screening visit
Weight (kg) measured wearing indoor clothing
Time frame: Screening visit
Height (cm) measured without shoes
Time frame: Screening visit
Adipositiy index calculated as body weight (kg) divided by squared height (in m)
Time frame: Screening visit
Score in the NEO-Five Factor Inventory 60 item validated questionnaire. The score for each central domain of normal personality defined by the Five-Factor Model of personality (neuroticism, extraversion, conscientiousness, agreeableness, and openness to experience) is calculated. A higher score on a scale assessing a certain personality domain indicates a stronger expression of traits associated with this particular domain.
Time frame: Screening visit (on-line questionnaire at home)
Score in the Trait Meta-Mood Scale-24 validated questionnaire. The score for three different dimensions of emotional intelligence are calculated. To obtain a score for each factor, items 1 to 8 are added for the emotional attention factor, items 9 to 16 for the emotional clarity factor, and items 17 to 24 for the emotional repair factor.
Time frame: Screening visit (on-line questionnaire at home)
Score in the Profile of Mood States validated questionnaire. The score for six different dimensions of mood (tension, anger, fatigue, depression, confusion, and vigour) is calculated. A higher score on a scale assessing a certain mood dimension indicates a stronger expression of associated feelings. The resulting scores will range from -24 to 177, with lower scores indicative of people with more stable mood profiles.
Time frame: Screening visit
Combined 100 mm visual analogue scale scores for liking of the test meal components
Time frame: Screening visit
Combined 100 mm visual analogue scale scores for familiarity with the test meal components
Time frame: Pre-screening (on-line questionnaire at home)
Score in the Eating Attitudes Test-26, ranging from 0-78 points, validated by Garner et al., 1982. Scores above 20 suggest risk for presence of potential eating disorders.
Time frame: Pre-screening (on-line questionnaire at home)
Score in the Perceived Stress Scale validated questionnaire. Scores ranging from 0 to 13 suggest low stress, scores ranging from 14 to 24 suggest moderate stress, and scores above 27 suggest high perceived stress.
Time frame: Screening
Profile defined by the combined Restraint (0-21 points), Disihnibition (0-16 points) and Susceptibilty to hunger (0-14 points) sub-scales scores of the Three Factor Eating Questionnaire (TFEQ), validated by Stunkard & Messick, 1985. Restraint values above 11, disinhibition values above 8 and susceptibility to hunger values above 4 are considered worse outcomes (i.e. risk for development of obesity and other eating disorders).
Time frame: Screening
Self-reported consumption habits and awareness of beverage portion size (pre-piloted on-line BPS survey)
Time frame: Clinical Investigation Day 2
Opinions from the participant in regards to the perceived acceptability, usefulness and areas of improvement for a set of novel portion-control tools including a lunchbox, measuring cup and commercial portion-control plate (collected via interview)
Clinica Universidad de Navarra, Universidad de Navarra
Other
Acute Intervention to Assess the Impact of Practical Strategies to Facilitate a Balanced and Healthy Diet
Acronym: PORTIONS-3
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02075710
Body Weight, Nutrition Disorders
San Francisco, California, United States
View Trial DetailsNCT07717814
Body Weight, Nutrition Disorders
Anaheim, California, United States
View Trial DetailsNCT07313761
Body Weight, Nutrition Disorders
Anaheim, California, United States
View Trial DetailsNCT05330247
Body Weight, Diabetes Mellitus
Copenhagen, Copenhagen NV, Denmark
View Trial Details